The Latinx/a/o and Hispanic population is the fastest-growing ethnic minority group in the United States (US) with a projected increase from 18.7% in 2020 to 28% by 2060. Among Latina and Hispanic women in the US, breast cancer (BCa) is the leading cancer diagnosed and cause of cancer deaths.…
The Latinx/a/o and Hispanic population is the fastest-growing ethnic minority group in the United States (US) with a projected increase from 18.7% in 2020 to 28% by 2060. Among Latina and Hispanic women in the US, breast cancer (BCa) is the leading cancer diagnosed and cause of cancer deaths. One major health concern among BCa survivors is metabolic dysregulation (MetD), defined as biomarkers associated with metabolic syndrome, insulin resistance, and visceral adiposity, where Latina and Hispanic populations are 1.5 times more likely to present with MetD when compared to non-Hispanic White and African American women. Further, Latinas and Hispanics are less likely to participate in exercise and seek preventive medical attention, influencing the onset and severity of comorbidities and negatively impacting survivorship. Thus, we completed the ROSA trial, a randomized controlled trial examining the effects of a virtually supervised exercise intervention on MetD in sedentary, obese Latina and Hispanic BCa survivors initiated during the COVID-19 pandemic.
